Welcome, Guest. Please login or register.
April 20, 2024, 07:30:55 am

Login with username, password and session length


Members
  • Total Members: 6307
  • Latest: golfer
Stats
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 91
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 89
Total: 89

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Report Raises Concerns About the Safety of Hepatitis C Treatments  (Read 5700 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
A new report suggests that in a relatively small number of cases the direct-acting antivirals (DAAs) used to treat hepatitis C virus (HCV) may in fact contribute to the very sort of severe liver disease the treatment is meant to prevent, The New York Times reports.

This finding comes from a report from the Institute for Safe Medication Practices, a nonprofit in Horsham, Pennsylvania, that studies the safety of drugs. The group analyzed the U.S. Food and Drug Administration’s (FDA) database on the reports doctors worldwide submit about adverse health events possibly associated with medications.

Read more...
https://www.hepmag.com/article/report-raises-concerns-safety-hep-c-treatments

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: Report Raises Concerns About the Safety of Hepatitis C Treatments
« Reply #1 on: February 12, 2017, 11:01:46 pm »
This report is seriously flawed. The best reply I've seen is from Doug Dietrich at http://www.mdmag.com/medical-news/liver-specialist-refutes-study-claiming-hepatitis-c-drug-dangers  I blogged on it ass well: https://www.hepmag.com/blog/hepatitis-c-news-reading-lines
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.